Back | Next |
home / stock / nbix / nbix message board
Subject | By | Source | When |
---|---|---|---|
I predict $NBIX will be $117.43 (or more) | Kagami | investorshub | 11/10/2017 5:45:48 AM |
Hi guys! Any forecasts on price targets? I'm contemplating | jtf3 | investorshub | 11/03/2017 8:47:06 PM |
$NBIX buy 50.20 | stocktrademan | investorshub | 07/27/2017 3:14:25 PM |
$NBIX bullish 52.71 | stocktrademan | investorshub | 05/11/2017 4:40:41 PM |
Nice win here!! Great news, should continue higher | rightothesky | investorshub | 04/12/2017 1:45:51 PM |
$52.28 NHOD!! | TheFinalCD | investorshub | 04/12/2017 1:12:47 PM |
Ya, that big buy at $49 was a | rightothesky | investorshub | 04/12/2017 12:04:21 PM |
HIT $51.99 SO FAR | TheFinalCD | investorshub | 04/12/2017 11:25:10 AM |
Wow. Sure is! | rightothesky | investorshub | 04/11/2017 10:12:22 PM |
9300 TRADE @ $49 | TheFinalCD | investorshub | 04/11/2017 10:08:01 PM |
Anyone wanna throw some predictions out there? | rightothesky | investorshub | 04/11/2017 10:04:35 PM |
FDA Approval........ | TheFinalCD | investorshub | 04/11/2017 10:02:55 PM |
Neurocrine Announces FDA Approval of INGREZZA (valbenazine) Capsules | TheFinalCD | investorshub | 04/11/2017 9:44:14 PM |
nice upside | gregque | investorshub | 04/11/2017 9:40:08 PM |
Ah movement on news | Awl416 | investorshub | 04/11/2017 9:30:20 PM |
This 10yr DCF implies Neurocrine Biosciences $NBIX is | ValueInvestor15 | investorshub | 02/14/2017 1:33:11 PM |
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are trading | AnthonyJackson | investorshub | 01/18/2017 2:41:39 PM |
AnthonyJackson6: Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are trading lower by over 5% a | AnthonyJackson6 | investorshangout | 01/18/2017 2:36:05 PM |
Hattlem: $NBIX immediate resistance @ the 10 DMA but still looks like it wants higher on the daily | Hattlem | investorshangout | 02/15/2016 2:04:24 PM |
Lucky Jimmy: Right on, I will be watching for them ty. | Lucky Jimmy | investorshangout | 01/22/2016 3:56:06 PM |
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
NASDAQ Market:
Neurocrine Biosciences Inc. Website:
Neurocrine Biosciences to Participate at Investor Conferences in June PR Newswire Jefferies Global Healthcare Conference on June 5 in New York Goldman Sachs 45 th Annual Global Healthcare Conference on June 13 in Miami SAN DIEGO , ...
Neurocrine Biosciences Announces CEO Succession Plan PR Newswire Board of Directors appoints Kyle Gano , Ph.D., Chief Business Development and Strategy Officer, as CEO-elect, effective October 11, 2024 Kevin Gorman , Ph.D., to continue to serve on the ...
Neurocrine Biosciences to Present New Phase 3 CAHtalyst™ Data in Adult and Pediatric Patients with CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ENDO 2024 PR Newswire New CAHtalyst™ Pediatric and CAHtalyst!...